Raúl J. Andrade

25.4k total citations · 6 hit papers
256 papers, 11.7k citations indexed

About

Raúl J. Andrade is a scholar working on Pharmacology, Hepatology and Epidemiology. According to data from OpenAlex, Raúl J. Andrade has authored 256 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Pharmacology, 88 papers in Hepatology and 85 papers in Epidemiology. Recurrent topics in Raúl J. Andrade's work include Drug-Induced Hepatotoxicity and Protection (168 papers), Liver Disease Diagnosis and Treatment (81 papers) and Pharmacogenetics and Drug Metabolism (80 papers). Raúl J. Andrade is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (168 papers), Liver Disease Diagnosis and Treatment (81 papers) and Pharmacogenetics and Drug Metabolism (80 papers). Raúl J. Andrade collaborates with scholars based in Spain, United States and United Kingdom. Raúl J. Andrade's co-authors include M. Isabel Lucena, Einar S. Björnsson, Guruprasad P. Aithal, Neil Kaplowitz, Mercedes Robles‐Díaz, Miren García‐Cortés, Camilla Stephens, Gerd A. Kullak‐Ublick, Manuel Romero‐Gómez and Dominique Larrey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Raúl J. Andrade

246 papers receiving 11.3k citations

Hit Papers

Drug-Induced Liver Injury: An Analysis of 461 Incidences ... 2005 2026 2012 2019 2005 2011 2019 2005 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
    2005 740 citations Raúl J. Andrade, M. Isabel Lucena et al. Gastroenterology profile →
  2. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
    2011 713 citations Guruprasad P. Aithal, Raúl J. Andrade et al. Clinical Pharmacology & Therapeutics profile →
  3. EASL Clinical Practice Guidelines: Drug-induced liver injury
    2019 710 citations Raúl J. Andrade, Guruprasad P. Aithal et al. Journal of Hepatology profile →
  4. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
    2005 556 citations Manuel Romero‐Gómez, Raúl J. Andrade et al. Gastroenterology profile →
  5. Drug-induced liver injury
    2019 537 citations Raúl J. Andrade, Einar S. Björnsson et al. profile →
  6. Drug-induced liver injury: recent advances in diagnosis and risk assessment
    2017 344 citations Gerd A. Kullak‐Ublick, Raúl J. Andrade et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raúl J. Andrade Spain 51 6.9k 4.3k 3.8k 2.3k 1.2k 256 11.7k
Dominique Larrey France 56 4.1k 0.6× 4.1k 1.0× 4.1k 1.1× 2.0k 0.8× 1.2k 1.0× 329 10.8k
M. Isabel Lucena Spain 45 5.2k 0.8× 2.0k 0.5× 1.6k 0.4× 1.7k 0.7× 807 0.7× 195 7.4k
Timothy J. Davern United States 31 5.1k 0.7× 2.8k 0.7× 4.0k 1.1× 1.2k 0.5× 513 0.4× 55 8.4k
Einar S. Björnsson Iceland 65 6.3k 0.9× 7.9k 1.8× 6.8k 1.8× 2.6k 1.1× 1.2k 1.0× 311 17.4k
Guruprasad P. Aithal United Kingdom 58 5.0k 0.7× 8.1k 1.9× 4.8k 1.3× 2.9k 1.3× 1.8k 1.6× 304 16.5k
Laura P. James United States 44 3.7k 0.5× 1.1k 0.3× 1.7k 0.4× 1.1k 0.5× 1.1k 0.9× 201 7.5k
Mitchell R. McGill United States 42 4.4k 0.6× 1.9k 0.4× 2.3k 0.6× 1.3k 0.5× 1.7k 1.5× 100 7.1k
Herbert L. Bonkovsky United States 75 3.6k 0.5× 7.7k 1.8× 7.4k 2.0× 1.6k 0.7× 6.7k 5.8× 369 20.0k
William Bernal United Kingdom 48 3.6k 0.5× 4.4k 1.0× 6.2k 1.6× 587 0.3× 701 0.6× 184 10.3k
Paul B. Watkins United States 73 11.5k 1.7× 2.3k 0.5× 1.9k 0.5× 6.2k 2.7× 3.5k 3.0× 246 19.9k

Countries citing papers authored by Raúl J. Andrade

Since Specialization
Citations

This map shows the geographic impact of Raúl J. Andrade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl J. Andrade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl J. Andrade more than expected).

Fields of papers citing papers by Raúl J. Andrade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raúl J. Andrade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl J. Andrade. The network helps show where Raúl J. Andrade may publish in the future.

Co-authorship network of co-authors of Raúl J. Andrade

This figure shows the co-authorship network connecting the top 25 collaborators of Raúl J. Andrade. A scholar is included among the top collaborators of Raúl J. Andrade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl J. Andrade. Raúl J. Andrade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villanueva‐Paz, Marina, Hao Niu, Ismael Álvarez‐Álvarez, et al.. (2024). Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network. Journal of Hepatology. 81(4). 630–640. 6 indexed citations
2.
Ho‐Plagaro, Ailec, Carlos Lopez‐Gómez, Flores Martín‐Reyes, et al.. (2023). Membrane Vesicles of Toxigenic Clostridioides difficile Affect the Metabolism of Liver HepG2 Cells. Antioxidants. 12(4). 818–818. 10 indexed citations
3.
Niu, Hao, Ismael Álvarez‐Álvarez, Aida Ortega‐Alonso, et al.. (2023). Evaluation of diagnostic and prognostic candidate biomarkers in drug‐induced liver injury vs. other forms of acute liver damage. British Journal of Clinical Pharmacology. 89(8). 2497–2507. 15 indexed citations
4.
Hayashi, Paul H., M. Isabel Lucena, Robert J. Fontana, et al.. (2022). A revised electronic version of RUCAM for the diagnosis of DILI. Repositorio Institucional de la Universidad de Málaga (University of Málaga). 74 indexed citations
5.
Björnsson, Einar S., Camilla Stephens, Edmond Atallah, et al.. (2022). A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry. Liver International. 43(1). 115–126. 35 indexed citations
6.
Lopez‐Gómez, Carlos, et al.. (2021). Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B. 11(12). 3685–3726. 45 indexed citations
7.
Crespo, Javier, Raúl J. Andrade, Fernando Alberca de las Parras, et al.. (2020). Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG. Gastroenterología y Hepatología (English Edition). 43(6). 332–347. 9 indexed citations
8.
Álvarez‐Álvarez, Ismael, Inmaculada Medina‐Cáliz, Judith Sanabria‐Cabrera, et al.. (2020). Clinical Characteristics and Outcome of Drug‐Induced Liver Injury in the Older Patients: From the Young‐Old to the Oldest‐Old. Clinical Pharmacology & Therapeutics. 109(4). 1147–1158. 17 indexed citations
9.
Turnés, Juan, Roberto Díaz‐Peña, Manuel Hernández‐Guerra, et al.. (2015). Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España. Gastroenterología y Hepatología. 38(4). 263–273. 4 indexed citations
10.
Ulzurrun, Eugenia, Camilla Stephens, Francisco Ruiz‐Cabello, et al.. (2014). Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort. PLoS ONE. 9(4). e94675–e94675. 14 indexed citations
11.
Andrade, Raúl J., et al.. (2011). Paracetamol e hígado Acetaminophen and the liver. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Lucena, M. Isabel, et al.. (2010). Genética y hepatotoxicidad. Gastroenterología y Hepatología. 33. 10–21. 1 indexed citations
13.
García‐Cortés, Miren, M. Isabel Lucena, Y. Borraz, et al.. (2008). Análisis de las causas, características y consecuencias de la reexposición al fármaco o compuesto responsable de un episodio de hepatotoxicidad. Revista Española de Enfermedades Digestivas. 100(5). 278–84. 10 indexed citations
14.
Andrade, Raúl J. & Mercedes Robles‐Díaz. (2008). Hepatotoxicidad por antibióticos: actualización en 2008. Revista española de quimioterapia. Suplemento. 21(4). 224–233. 9 indexed citations
15.
Lucena, M. Isabel, et al.. (2008). Assessment of drug‐induced liver injury in clinical practice. Fundamental and Clinical Pharmacology. 22(2). 141–158. 55 indexed citations
16.
García-García, José Ángel, Manuel Romero‐Gómez, J.A. Girón González, et al.. (2006). Incidence of and Factors Associated with Hepatocellular Carcinoma among Hepatitis C Virus and Human Immunodeficiency Virus Coinfected Patients with Decompensated Cirrhosis. AIDS Research and Human Retroviruses. 22(12). 1236–1241. 15 indexed citations
17.
18.
Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández‐Santaella, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 740 indexed citations breakdown →
19.
Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 66 indexed citations
20.
Romero‐Gómez, Manuel, I. Wichmann, Javier Crespo, et al.. (2004). Serum Immunological Profile in Patients with Chronic Autoimmune Cholestasis. The American Journal of Gastroenterology. 99(11). 2150–2157. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Larrey Breakdown of academic impact, for papers by M. Isabel Lucena Breakdown of academic impact, for papers by Timothy J. Davern Breakdown of academic impact, for papers by Einar S. Björnsson Breakdown of academic impact, for papers by Guruprasad P. Aithal Breakdown of academic impact, for papers by Laura P. James Breakdown of academic impact, for papers by Mitchell R. McGill Breakdown of academic impact, for papers by Herbert L. Bonkovsky Breakdown of academic impact, for papers by William Bernal Breakdown of academic impact, for papers by Paul B. Watkins
Rankless by CCL
2026